pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·39m ago·1 min read
save

DOJ ramps up health-care fraud investigations, urges companies to self-report and reward remediation

Oct 15, 2026·read at STAT ↗RegulatoryNegative

At the STAT Summit in Boston, DOJ officials announced a renewed focus on health-care fraud, especially targeting Medicare and Medicaid schemes.

Deputy Assistant Attorney General Jacob Foster said the agency will use AI tools, whistleblower tips, and voluntary self-disclosures to identify large fraud schemes.

Companies will have a "one-stop shop" to file self-reports, and the DOJ says it will consider remediation efforts when deciding on enforcement, effectively rewarding proactive compliance.

The message to health-care executives is clear: avoid the fate of Theranos by cooperating early, as the administration intensifies its enforcement posture.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The Trump administration is doubling down on health care fraud investigations”

read at STAT ↗
684 words · retrieved 28m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoMass. lawmaker Auchincloss favors boosting U.S. biotech over targeting ChinaSTAT
  • 2h agoSTAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadershipSTAT
  • 3h agoSTAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancerSTAT
  • 3h agoAfter a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forwardSTAT
  • 5h agoSTAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and moreSTAT